Constitution of a Biobank for Studies Related to Organ Transplantation (Lyon Centaure Biocollection)

February 28, 2024 updated by: Hospices Civils de Lyon

Biological Material Bank for Studies Related to Organ Transplantation

This study aims to constitute a collection of biological materials from in transplant patients and to provide biological materials from transplanted patients in order :

i) validate new theory on the cause of allograft loss, ii) develop innovative biomarker for rejection and other transplantation-related conditions (such as BK virus nephropathy, Post-transplant lymphoproliferative disorder ( PTLD) ...)

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

4000

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

All adult patients that received a solid organ transplant at the transplantation department of Lyon University Hospital

Description

Inclusion Criteria:

  • Male or Female patient ≥18 years old
  • Recipient of an organ transplant
  • Written informed consent

Exclusion Criteria:

  • Non-affiliation to a social security system.
  • Subjects deprived of liberties
  • Pregnant or breastfeeding woman

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
the biological samples
Time Frame: At inclusion
The goal of this study is to provide biological materials from transplanted patients
At inclusion
Change Biological Samples
Time Frame: Month 1
The goal of this study is to provide biological materials from transplanted patients
Month 1
Change Biological Samples
Time Frame: Month 3
The goal of this study is to provide biological materials from transplanted patients
Month 3
Change Biological Samples
Time Frame: Month 6
The goal of this study is to provide biological materials from transplanted patients
Month 6
Change Biological Samples
Time Frame: Month 12
The goal of this study is to provide biological materials from transplanted patients
Month 12
Change Biological Samples
Time Frame: Month 60
The goal of this study is to provide biological materials from transplanted patients
Month 60
Change Biological Samples
Time Frame: Month 120
The goal of this study is to provide biological materials from transplanted patients
Month 120

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Hospices Civils de Lyon

Investigators

  • Principal Investigator: Olivier Thaunat, MD, Edouard Herriot Hospital - Transplantation department

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 8, 2020

Primary Completion (Estimated)

January 8, 2040

Study Completion (Estimated)

January 8, 2040

Study Registration Dates

First Submitted

December 16, 2020

First Submitted That Met QC Criteria

December 28, 2020

First Posted (Actual)

December 29, 2020

Study Record Updates

Last Update Posted (Estimated)

February 29, 2024

Last Update Submitted That Met QC Criteria

February 28, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Other Study ID Numbers

  • 69HCL20_0964

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Organ Transplantation

Clinical Trials on Biobank

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Lithuania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

3
Subscribe